Here's what interactive, virtual events to log on to this month. Katleho Seisa/Getty Images

Going into April, the city of Houston has another month at least of working from home, hopping on calls, and setting up video chats — but you don't have to go through this all alone.

Here are over 10 Houston innovation events you can attend virtually via online meetings. Be sure to register in advance, as most will send an access link ahead of the events.

April 1 — Social Entrepreneurship Meetup

Impact Hub Houston is bringing this monthly meetup online. Registrants will receive an email with the link to attend the Zoom meeting.


Details: The event is at 5:30 pm on Wednesday, April 1. Learn more.

April 2 — Considerations for Emerging Companies in the COVID-19 Era

A group of experts will discuss how the coronavirus and all its resulting complications will affect startups.

Details: The event is at 2 pm on Thursday, April 2. Learn more.

April 3 — UH's Red Labs Pitch Madness

You are invited to watch the final round of Pitch Madness, a pitch competition for UH students. Students will give a four minute pitch and be asked questions about their startup idea by judges. You can attend digitally the finals and watch students pitch at bit.ly/pitchmadness_finals.

Details: The event is at 1 pm on Friday, April 3. Learn more.

April 7 — CARES Act and Managing your Startup through the COVID Crisis

Carolyn Rodz, CEO of Alice, and Aziz Gilani, managing director of Mercury Fund, answer tech startups' questions about the CARES Act. Zoom link will be sent to attendee's prior to the event.

Details: The event is at 4 pm on Tuesday, April 7. Learn more.

April 8 — Startups & Sustainability - How to Make a Profit and Impact

Join as General Assembly brings together entrepreneurs in sustainability to examine how business and tech can be a force for good. Hear from leaders who will share their insights into how industry can impact the environment. Event will be hosted via Zoom, and registrants will be sent a link to attend.

Details: The event is at 5:45 pm on Wednesday, April 8. Learn more.

April 9 — Out of the Lab & Into the Newsroom: Media 101

This JLABs webinar will discuss trends in the media world, how these impact best outreach practices, and tips for designing a successful media campaign.

Details: The event is at 9 am on Thursday, April 9. Learn more.

April 9 — Webinar: In Today's Market - Do Patents Even Matter?

Inventors and business professionals are asked to review the claims of their patent application before it is filed. This step is THE critical step that is supposed to ensure that the claims will protect their invention. The decision you make here determines if you will be part of the 97% of all patents that never recoup the cost of filing them. This event is virtual and a Zoom link will be emailed on the day of the event.

Details: The event is at noon on Thursday, April 9. Learn more.

April 13-16 — Capital Factory's Founders Academy Essentials

Amongst all the excitement of running a startup is a lot of hard work and stressful decisions. Founders Academy Essentials is a 4-day lunch-n-learn curriculum designed specifically for driven entrepreneurs that are passionate about their business potential.

Details: The event is from Monday, April 13, to Thursday, April 16. Learn more.

April 14 — Black in Tech Summit

Capital Factory welcomes you to its 2nd Annual Black In Tech Summit. We're dedicated to increasing diversity in the tech community and making our coworking space an inclusive environment for people of all backgrounds and identities.

Details: The event is at noon on Tuesday, April 14. Learn more.

April 21 — Don’t Go Pitching in the Dark: How to Navigate Investor Interactions

In this webinar, experts of the craft will share practical tips on becoming more effective in communicating your story to investors, increasing your chances of successful fundraising.

Details: The event is at 9 am on Tuesday, April 21. Learn more.

April 21 — Employable in 2030: Closing the skills gap.

What jobs will exist in 2030? Come along and hear from a panel of industry leaders on how to stay relevant in the rapidly changing space for 2030 and beyond. Event will be hosted via Zoom, and registrants will be sent a link to attend.

Details: The event is at 7 pm on Tuesday, April 21. Learn more.

April 22 — Ion Startup Demo Day (Virtual Edition)

Top tier mentors, local investors, and personalized pitch feedback for participating startups -- nothing's changed but the address. Whether you're a serial entrepreneur or just looking to get involved in the community, this event is for YOU.

Details: The event is at 6 pm on Wednesday, April 22. Learn more.

------

For more virtual events, check out Houston Exponential's calendar.

Ad Placement 300x100
Ad Placement 300x600

CultureMap Emails are Awesome

Axiom Space-tested cancer drug advances to clinical trials

mission critical

A cancer-fighting drug tested aboard several Axiom Space missions is moving forward to clinical trials.

Rebecsinib, which targets a cancer cloning and immune evasion gene, ADAR1, has received FDA approval to enter clinical trials under active Investigational New Drug (IND) status, according to a news release. The drug was tested aboard Axiom Mission 2 (Ax-2) and Axiom Mission 3 (Ax-3). It was developed by Aspera Biomedicine, led by Dr. Catriona Jamieson, director of the UC San Diego Sanford Stem Cell Institute (SSCI).

The San Diego-based Aspera team and Houston-based Axiom partnered to allow Rebecsinib to be tested in microgravity. Tumors have been shown to grow more rapidly in microgravity and even mimic how aggressive cancers can develop in patients.

“In terms of tumor growth, we see a doubling in growth of these little mini-tumors in just 10 days,” Jamieson explained in the release.

Rebecsinib took part in the patient-derived tumor organoid testing aboard the International Space Station. Similar testing is planned to continue on Axiom Station, the company's commercial space station that's currently under development.

Additionally, the drug will be tested aboard Ax-4 under its active IND status, which was targeted to launch June 25.

“We anticipate that this monumental mission will inform the expanded development of the first ADAR1 inhibitory cancer stem cell targeting drug for a broad array of cancers," Jamieson added.

According to Axiom, the milestone represents the potential for commercial space collaborations.

“We’re proud to work with Aspera Biomedicines and the UC San Diego Sanford Stem Cell Institute, as together we have achieved a historic milestone, and we’re even more excited for what’s to come,” Tejpaul Bhatia, the new CEO of Axiom Space, said in the release. “This is how we crack the code of the space economy – uniting public and private partners to turn microgravity into a launchpad for breakthroughs.”